FMP
NASDAQ
18.21 USD
0.22 (1.21%)
Mr. Kevin Hykes
Healthcare
Medical - Devices
https://www.cvrx.com
NASDAQ
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
0001235912
US1266381052
126638105
9201 West Broadway Avenue
763 416 2840
US
200
Jun 30, 2021
0001235912
NASDAQ
Medical - Devices
Healthcare
126638105
US1266381052
US
18.21
1.26
153.61k
381.09M
-
8.38-33.135
-0.18
-
-
-
-
-9.15
-
https://www.cvrx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.